630 related articles for article (PubMed ID: 2902851)
1. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
Scully MF; Ellis V; Seno N; Kakkar VV
Biochem J; 1988 Sep; 254(2):547-51. PubMed ID: 2902851
[TBL] [Abstract][Full Text] [Related]
2. Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways.
Ofosu FA; Modi GJ; Smith LM; Cerskus AL; Hirsh J; Blajchman MA
Blood; 1984 Sep; 64(3):742-7. PubMed ID: 6235872
[TBL] [Abstract][Full Text] [Related]
3. Heparin cofactor II and other endogenous factors in the mediation of the antithrombotic and anticoagulant effects of heparin and dermatan sulfate.
Ofosu FA; Fernandez F; Gauthier D; Buchanan MR
Semin Thromb Hemost; 1985 Apr; 11(2):133-7. PubMed ID: 3898370
[No Abstract] [Full Text] [Related]
4. The anticoagulant properties of mast cell product, chondroitin sulphate E.
Scully MF; Ellis V; Seno N; Kakkar VV
Biochem Biophys Res Commun; 1986 May; 137(1):15-22. PubMed ID: 3087353
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
Ofosu FA
Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
[TBL] [Abstract][Full Text] [Related]
6. Antithrombin activity of fucoidan. The interaction of fucoidan with heparin cofactor II, antithrombin III, and thrombin.
Church FC; Meade JB; Treanor RE; Whinna HC
J Biol Chem; 1989 Feb; 264(6):3618-23. PubMed ID: 2914965
[TBL] [Abstract][Full Text] [Related]
7. Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin III.
Koyama T; Parkinson JF; Sié P; Bang NU; Müller-Berghaus G; Preissner KT
Eur J Biochem; 1991 Jun; 198(3):563-70. PubMed ID: 1646716
[TBL] [Abstract][Full Text] [Related]
8. The anticoagulant activity of dermatan sulphates: evidence against the involvement of antithrombin III.
Kindness G; Long WF; Williamson FB
Br J Pharmacol; 1981 Jan; 72(1):81-8. PubMed ID: 7225714
[TBL] [Abstract][Full Text] [Related]
9. Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate.
Ofosu FA; Buchanan MR; Anvari N; Smith LM; Blajchman MA
Ann N Y Acad Sci; 1989; 556():123-31. PubMed ID: 2525356
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of potentiation of antithrombin III and heparin cofactor II inhibition by sulfated xylans.
Carson L; Doctor VM
Thromb Res; 1990 May; 58(4):367-81. PubMed ID: 1972302
[TBL] [Abstract][Full Text] [Related]
11. The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate.
Ofosu FA; Blajchman MA; Modi GJ; Smith LM; Buchanan MR; Hirsh J
Br J Haematol; 1985 Aug; 60(4):695-704. PubMed ID: 2411283
[TBL] [Abstract][Full Text] [Related]
12. Effect of a heparan sulphate with high affinity for antithrombin III upon inactivation of thrombin and coagulation factor Xa.
Scully MF; Ellis V; Shah N; Kakkar V
Biochem J; 1989 Sep; 262(2):651-8. PubMed ID: 2529852
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of factor X and factor V activation by dermatan sulfate and a pentasaccharide with high affinity for antithrombin III in human plasma.
Ofosu FA; Choay J; Anvari N; Smith LM; Blajchman MA
Eur J Biochem; 1990 Oct; 193(2):485-93. PubMed ID: 2226466
[TBL] [Abstract][Full Text] [Related]
14. [Antiocoagulant activity of chondroitin sulfate A, B and C.--co-operative action with heparin cofactor (author's transl)].
Shiba T; Takeuchi S; Awazu S; Igarashi M; Asada T
Nihon Ketsueki Gakkai Zasshi; 1978 Jun; 41(3):560-3. PubMed ID: 696196
[No Abstract] [Full Text] [Related]
15. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.
Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA
Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525
[TBL] [Abstract][Full Text] [Related]
16. Activation of heparin cofactor II by dermatan sulfate.
Tollefsen DM; Pestka CA; Monafo WJ
J Biol Chem; 1983 Jun; 258(11):6713-6. PubMed ID: 6687888
[TBL] [Abstract][Full Text] [Related]
17. Activation of heparin cofactor II by heparin and dermatan sulfate.
Tollefsen DM
Nouv Rev Fr Hematol (1978); 1984; 26(4):233-7. PubMed ID: 6548014
[TBL] [Abstract][Full Text] [Related]
18. Dermatan sulfate and heparin can be fractionated by affinity for heparin cofactor II.
Griffith MJ; Marbet GA
Biochem Biophys Res Commun; 1983 Apr; 112(2):663-70. PubMed ID: 6687802
[TBL] [Abstract][Full Text] [Related]
19. [Dermatan sulfate and the prevention of experimental venous thrombosis].
Desnoyers P; Bara L; Samama M
Pathol Biol (Paris); 1989 Jun; 37(6):759-67. PubMed ID: 2674877
[TBL] [Abstract][Full Text] [Related]
20. Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides.
Sie P; Ofosu F; Fernandez F; Buchanan MR; Petitou M; Boneu B
Br J Haematol; 1986 Dec; 64(4):707-14. PubMed ID: 2432917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
